Nucleix's Bladder EpiCheck™, Urine Test for Monitoring Bladder Cancer, Chosen as Standard-of-Care by Radboud University Medical Center

By In The News
January 30, 2019 in The Headlines

Recommended Posts

In The News

Posted January 30, 2019

- Share

Posted January 30, 2019

REHOVOT, Israel, Jan. 30, 2019 /PRNewswire/ -- Nucleix Ltd., a leading cancer detection and screening company, announced today that Radboud University Medical Center (UMC) in Nijmegen, the Netherlands has chosen to add the Company's Bladder EpiCheck™, a urine test for the monitoring of...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  222969
2. Jaydee
  18349
3. deicer
  13866
4. Kip Powick
  12388
5. dagger
  9619
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  273.4k
- Total Posts
  
  567.8k

Sign In

Nucleix's Bladder EpiCheck™, Urine Test for Monitoring Bladder Cancer, Chosen as Standard-of-Care by Radboud University Medical Center

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support